Vandana Agarwal, MD
Hematology/Oncology · Pomona
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 45 years
- Graduated 1981
Offices
1 location · Los Angeles Hematology-Oncology Medical Group · 51 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Agarwal’s office at (909) 620-5502 to ask if they take your plan before you enroll.
California Medical Board record
Licence A41760 · Current
Licensed to practise in California · since 1985 · expires 2028-07-31 · Bhopal University, Gandhi Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$238,080
Medicare paid this office $238,080 for 59 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 54 | $40,254 | $100 |
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 27 | $7,032 | $220 |
| Advance care planning, first 30 minutes | 31 | $2,611 | $67 |
| Assessment of emotional or behavioral problems | 21 | $96 | $5 |
Who their Medicare patients are
59 Original Medicare patients in 2024. Average age 69 · Under 65 24% · Women 49% · Also on Medicaid 76% · Health risk score 1.75. At or below the middle of the specialty; the typical hematology-oncology clinician is at 2.04.
Conditions among them: High blood pressure 75% · Diabetes 54% · Chronic kidney disease 27% · Coronary heart disease 24% · Cancer 24% · Depression 19%.
The office billed $663,017, Medicare allowed $302,345 and paid $238,080; for 11,531 services of 50 kinds; $170,903 of it was for drugs given in the office and $67,177 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 59 | 11,531 | 69 | 1.75 | $663,017 | $238,080 |
| 2023 | 65 | 17,511 | 68 | 1.78 | $713,673 | $277,020 |
| 2022 | 75 | 28,065 | 67 | 1.73 | $928,568 | $380,126 |
| 2021 | 116 | 20,288 | 64 | 1.64 | $971,660 | $407,898 |
| 2020 | 127 | 23,083 | 66 | 2.09 | $995,876 | $417,963 |
| 2019 | 135 | 73,375 | 66 | 2.27 | $1,226,076 | $497,433 |
| 2018 | 177 | 115,465 | 67 | 2.42 | $1,235,130 | $555,459 |
| 2017 | 195 | 59,877 | 67 | 2.31 | $946,146 | $414,780 |
| 2016 | 160 | 14,640 | 68 | 2.55 | $599,878 | $268,564 |
| 2015 | 113 | 9,157 | 68 | 2.36 | $436,977 | $189,639 |
| 2014 | 145 | 14,166 | 67 | 2.56 | $835,018 | $299,426 |
| 2013 | 173 | 39,632 | 69 | 2.58 | $2,712,615 | $953,251 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Return visit (30+ min) | 57 | $29,090 | $101 |
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 36 | $9,134 | $208 |
| Advance care planning, first 30 minutes | 31 | $2,530 | $63 |
| Infusion into a vein for hydration, each additional hour | 12 | $901 | $11 |
2022: 5 services
| Return visit (30+ min) | 61 | $32,637 | $106 |
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 35 | $8,298 | $193 |
| Advance care planning, first 30 minutes | 38 | $3,008 | $64 |
| Telephone medical discussion with physician, 11-20 minutes | 16 | $1,224 | $53 |
| Injection of drug or substance under skin or into muscle | 13 | $584 | $13 |
2021: 11 services
| Return visit (30+ min) | 88 | $41,916 | $109 |
| Administration of chemotherapy into vein, 1 hour or less | 11 | $14,593 | $139 |
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 43 | $10,001 | $227 |
| Telephone medical discussion with physician, 11-20 minutes | 32 | $6,297 | $76 |
| Advance care planning, first 30 minutes | 60 | $5,818 | $71 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 20 | $3,769 | $188 |
| New patient visit (60+ min) | 19 | $3,424 | $180 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 60 | $3,238 | $25 |
| Telephone medical discussion with physician, 21-30 minutes | 11 | $2,343 | $117 |
| Smoking and tobacco use intensive counseling, 4-10 minutes | 14 | $748 | $17 |
| Telephone medical discussion with physician, 5-10 minutes | 12 | $309 | $22 |
2020: 14 services
| Return visit (30+ min) | 80 | $34,538 | $92 |
| Injection, denosumab, 1 mg | 11 | $30,561 | None |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 94 | $19,673 | $31 |
| Administration of chemotherapy into vein, 1 hour or less | 12 | $18,627 | $129 |
| Short return visit (20+ min) | 81 | $13,464 | $63 |
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 44 | $10,675 | $184 |
| Telephone medical discussion with physician, 21-30 minutes | 46 | $9,119 | $96 |
| Advance care planning, first 30 minutes | 63 | $6,661 | $70 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 20 | $3,763 | $188 |
| Telephone medical discussion with physician, 11-20 minutes | 24 | $2,478 | $67 |
| Telephone medical discussion with physician, 5-10 minutes | 29 | $2,155 | $40 |
| Smoking and tobacco use intensive counseling, 4-10 minutes | 16 | $899 | $17 |
| Online digital evaluation and management service for an established patient for up to 7 days, total time 21 or more minutes | 16 | $771 | $43 |
| Injection of drug or substance under skin or into muscle | 11 | $482 | $13 |
2019: 11 services
| Injection, denosumab, 1 mg | 23 | $97,349 | None |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 111 | $28,336 | $33 |
| Return visit (30+ min) | 74 | $25,872 | $93 |
| Administration of chemotherapy into vein, 1 hour or less | 13 | $20,904 | $129 |
| Short return visit (20+ min) | 66 | $14,585 | $64 |
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 69 | $14,076 | $183 |
| Advance care planning, first 30 minutes | 69 | $6,906 | $73 |
| New patient visit (60+ min) | 21 | $3,581 | $171 |
| Injection of drug or substance under skin or into muscle | 28 | $2,023 | $15 |
| Injection of additional new drug or substance into vein | 11 | $1,708 | $15 |
| Smoking and tobacco use intensive counseling, 4-10 minutes | 16 | $1,285 | $16 |
2018: 11 services
| Injection, denosumab, 1 mg | 24 | $77,407 | None |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 162 | $32,670 | $33 |
| Return visit (30+ min) | 101 | $27,768 | $88 |
| Administration of chemotherapy into vein, 1 hour or less | 16 | $26,120 | $127 |
| Short return visit (20+ min) | 93 | $20,800 | $59 |
| Advance care planning, first 30 minutes | 100 | $8,197 | $64 |
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 19 | $3,948 | $208 |
| Injection of drug or substance under skin or into muscle | 31 | $3,649 | $18 |
| New patient visit (60+ min) | 20 | $3,431 | $172 |
| Smoking and tobacco use intensive counseling, 4-10 minutes | 17 | $810 | $16 |
| Injection of additional new drug or substance into vein | 11 | $789 | $16 |
2017: 9 services
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 178 | $38,345 | $34 |
| Return visit (30+ min) | 94 | $23,504 | $88 |
| Injection, denosumab, 1 mg | 14 | $23,479 | None |
| Short return visit (20+ min) | 110 | $21,214 | $59 |
| Administration of chemotherapy into vein, 1 hour or less | 16 | $11,498 | $122 |
| Advance care planning, first 30 minutes | 113 | $10,503 | $62 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 15 | $5,842 | $60 |
| Injection of drug or substance under skin or into muscle | 19 | $3,150 | $23 |
| New patient visit (45+ min) | 19 | $2,618 | $138 |
2016: 9 services
| Return visit (30+ min) | 76 | $22,634 | $88 |
| Short return visit (20+ min) | 100 | $21,893 | $56 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 13 | $12,340 | $61 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 17 | $7,423 | $86 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 17 | $5,977 | $60 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 97 | $4,612 | $33 |
| Advance care planning, first 30 minutes | 36 | $3,124 | $73 |
| New patient visit (60+ min) | 11 | $1,748 | $159 |
| New patient visit (45+ min) | 11 | $1,561 | $142 |
2015: 7 services
| Injection, denosumab, 1 mg | 16 | $27,237 | None |
| Return visit (30+ min) | 98 | $26,694 | $84 |
| Short return visit (20+ min) | 70 | $8,727 | $59 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 11 | $3,811 | $61 |
| New patient visit (60+ min) | 11 | $1,954 | $178 |
| Injection of drug or substance under skin or into muscle | 17 | $743 | $22 |
| Short return visit | 16 | $729 | $38 |
2014: 6 services
| Return visit (30+ min) | 115 | $37,324 | $85 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $16,967 | $58 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 24 | $12,604 | $85 |
| New patient visit (60+ min) | 33 | $5,424 | $164 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,829 | $166 |
| Short return visit (20+ min) | 15 | $1,498 | $58 |
2013: 21 services
| Return visit (30+ min) | 131 | $52,757 | $86 |
| Administration of chemotherapy into vein, 1 hour or less | 22 | $34,539 | $128 |
| Short return visit (20+ min) | 95 | $18,888 | $61 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 34 | $18,231 | $57 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 40 | $12,110 | $83 |
| Administration of additional new drug or substance into vein, 1 hour or less | 16 | $11,113 | $64 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $9,594 | $31 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 38 | $8,742 | $162 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 23 | $8,086 | $28 |
| Administration of chemotherapy into vein, each additional hour | 20 | $7,711 | $27 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 20 | $6,629 | $66 |
| Injection of additional new drug or substance into vein | 19 | $3,935 | $20 |
| New patient visit (60+ min) | 18 | $2,826 | $157 |
| Biopsy of bone marrow | 17 | $2,649 | $147 |
| New patient visit (45+ min) | 17 | $2,306 | $136 |
| Injection of drug or substance under skin or into muscle | 17 | $1,988 | $23 |
| Short return visit | 17 | $1,314 | $38 |
| Injection, ondansetron hydrochloride, per 1 mg | 23 | $511 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 21 | $277 | None |
| Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service | 17 | $189 | $11 |
| Injection, diphenhydramine hcl, up to 50 mg | 18 | $100 | None |
Medicaid work
$138,416 in 2024
Medicaid paid $138,416 for 12,394 billed services this clinician did in 2024, up to 174 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 2,446 | $64,938 |
| Advance care planning including the explanation and discussion of advance directives such as standard forms (with completion of such forms, when performed), by the physician or other qualified health care professional; first 30 minutes, face-to-face with the patient, family member(s), and/or surrogate | 631 | $25,590 |
| Injection, ferric carboxymaltose, 1 mg | 21 | $14,747 |
| Interprofessional telephone/Internet/electronic health record assessment and management service provided by a consultative physician or other qualified health care professional, including a written report to the patient's treating/requesting physician or other qualified health care professional, 5 minutes or more of medical consultative time | 315 | $10,868 |
| New patient visit (60+ min) | 185 | $9,501 |
| Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug | 147 | $4,075 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 40-64 years | 78 | $2,832 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 128 | $1,836 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure) | 39 | $1,693 |
| Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure) | 67 | $1,156 |
| Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour | 20 | $891 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 53 | $155 |
| 2024 | 12,394 | 46 | 174 | $138,416 |
| 2023 | 11,403 | 45 | 143 | $131,528 |
| 2022 | 11,318 | 44 | 206 | $153,449 |
| 2021 | 11,709 | 27 | 217 | $177,087 |
| 2020 | 11,778 | 54 | 208 | $123,404 |
| 2019 | 6,330 | 51 | 116 | $80,418 |
| 2018 | 4,289 | 15 | 108 | $94,266 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 1,859 | $49,421 |
| Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure) | 204 | $27,217 |
| Advance care planning including the explanation and discussion of advance directives such as standard forms (with completion of such forms, when performed), by the physician or other qualified health care professional; first 30 minutes, face-to-face with the patient, family member(s), and/or surrogate | 600 | $24,021 |
| New patient visit (60+ min) | 212 | $12,129 |
| Interprofessional telephone/Internet/electronic health record assessment and management service provided by a consultative physician or other qualified health care professional, including a written report to the patient's treating/requesting physician or other qualified health care professional, 5 minutes or more of medical consultative time | 211 | $7,280 |
| Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug | 196 | $5,521 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 40-64 years | 246 | $4,138 |
| Assessment of and care planning for a patient with cognitive impairment, requiring an independent historian, in the office or other outpatient, home or domiciliary or rest home, with all of the following required elements: Cognition-focused evaluation including a pertinent history and examination, Medical decision making of moderate or high complexity, Functional assessment (eg, basic and instrumental activities of daily living), including decision-making capacity, Use of standardized instruments for staging of dementia (eg, functional assessment staging test [FAST], clinical dementia rating [CDR]), Medication reconciliation and review for high-risk medications, Evaluation for neuropsychiatric and behavioral symptoms, including depression, including use of standardized screening instrument(s), Evaluation of safety (eg, home), including motor vehicle operation, Identification of caregiver(s), caregiver knowledge, caregiver needs, social supports, and the willingness of caregiver to take on caregiving tasks, Development, updating or revision, or review of an Advance Care Plan, Creation of a written care plan, including initial plans to address any neuropsychiatric symptoms, neuro-cognitive symptoms, functional limitations, and referral to community resources as needed (eg, rehabilitation services, adult day programs, support groups) shared with the patient and/or caregiver with initial education and support. Typically, 60 minutes of total time is spent on the date of the encounter. | 13 | $636 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 18-39 years | 15 | $494 |
| Smoking and tobacco use cessation counseling visit; intermediate, greater than 3 minutes up to 10 minutes | 65 | $262 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 17 | $219 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 59 | $140 |
2022
| Return visit (30+ min) | 2,366 | $65,427 |
| Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug | 151 | $40,300 |
| Advance care planning including the explanation and discussion of advance directives such as standard forms (with completion of such forms, when performed), by the physician or other qualified health care professional; first 30 minutes, face-to-face with the patient, family member(s), and/or surrogate | 689 | $22,924 |
| New patient visit (60+ min) | 200 | $12,599 |
| Interprofessional telephone/Internet/electronic health record assessment and management service provided by a consultative physician or other qualified health care professional, including a written report to the patient's treating/requesting physician or other qualified health care professional, 5 minutes or more of medical consultative time | 269 | $9,281 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 18-39 years | 60 | $1,333 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 40-64 years | 273 | $758 |
| Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure) | 44 | $673 |
| Smoking and tobacco use cessation counseling visit; intermediate, greater than 3 minutes up to 10 minutes | 13 | $155 |
| Urinary incontinence plan of care documented (GER) | 124 | $0 |
| Falls plan of care documented (GER) | 101 | $0 |
| Plan of care to address pain documented (COA) (ONC) | 49 | $0 |
2021
| Return visit (30+ min) | 3,683 | $109,836 |
| Advance care planning including the explanation and discussion of advance directives such as standard forms (with completion of such forms, when performed), by the physician or other qualified health care professional; first 30 minutes, face-to-face with the patient, family member(s), and/or surrogate | 780 | $29,175 |
| New patient visit (60+ min) | 328 | $22,092 |
| Interprofessional telephone/Internet/electronic health record assessment and management service provided by a consultative physician or other qualified health care professional, including a written report to the patient's treating/requesting physician or other qualified health care professional, 5 minutes or more of medical consultative time | 221 | $7,625 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 390 | $3,694 |
| Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug | 73 | $1,906 |
| Smoking and tobacco use cessation counseling visit; intermediate, greater than 3 minutes up to 10 minutes | 196 | $1,116 |
| Chronic care management services with the following required elements: multiple (two or more) chronic conditions expected to last at least 12 months, or until the death of the patient, chronic conditions that place the patient at significant risk of death, acute exacerbation/decompensation, or functional decline, comprehensive care plan established, implemented, revised, or monitored; first 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month. | 75 | $721 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 18-39 years | 100 | $425 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 40-64 years | 227 | $420 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 47 | $40 |
| Pain severity quantified; no pain present (COA) (ONC) | 1,347 | $37 |
2020
| Return visit (30+ min) | 2,557 | $66,001 |
| Advance care planning including the explanation and discussion of advance directives such as standard forms (with completion of such forms, when performed), by the physician or other qualified health care professional; first 30 minutes, face-to-face with the patient, family member(s), and/or surrogate | 755 | $21,701 |
| New patient visit (60+ min) | 352 | $15,212 |
| Interprofessional telephone/Internet/electronic health record assessment and management service provided by a consultative physician or other qualified health care professional, including a written report to the patient's treating/requesting physician or other qualified health care professional, 5 minutes or more of medical consultative time | 117 | $4,037 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 21-30 minutes of medical discussion | 113 | $2,925 |
| Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug | 151 | $2,343 |
| Short return visit (20+ min) | 285 | $2,137 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 330 | $1,767 |
| Chronic care management services with the following required elements: multiple (two or more) chronic conditions expected to last at least 12 months, or until the death of the patient, chronic conditions that place the patient at significant risk of death, acute exacerbation/decompensation, or functional decline, comprehensive care plan established, implemented, revised, or monitored; first 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month. | 349 | $1,631 |
| Assessment of and care planning for a patient with cognitive impairment, requiring an independent historian, in the office or other outpatient, home or domiciliary or rest home, with all of the following required elements: Cognition-focused evaluation including a pertinent history and examination, Medical decision making of moderate or high complexity, Functional assessment (eg, basic and instrumental activities of daily living), including decision-making capacity, Use of standardized instruments for staging of dementia (eg, functional assessment staging test [FAST], clinical dementia rating [CDR]), Medication reconciliation and review for high-risk medications, Evaluation for neuropsychiatric and behavioral symptoms, including depression, including use of standardized screening instrument(s), Evaluation of safety (eg, home), including motor vehicle operation, Identification of caregiver(s), caregiver knowledge, caregiver needs, social supports, and the willingness of caregiver to take on caregiving tasks, Development, updating or revision, or review of an Advance Care Plan, Creation of a written care plan, including initial plans to address any neuropsychiatric symptoms, neuro-cognitive symptoms, functional limitations, and referral to community resources as needed (eg, rehabilitation services, adult day programs, support groups) shared with the patient and/or caregiver with initial education and support. Typically, 60 minutes of total time is spent on the date of the encounter. | 29 | $1,442 |
| Online digital evaluation and management service, for an established patient, for up to 7 days, cumulative time during the 7 days; 21 or more minutes | 65 | $1,376 |
| New patient visit (45+ min) | 17 | $1,022 |
2019
| Return visit (30+ min) | 1,239 | $33,309 |
| Advance care planning including the explanation and discussion of advance directives such as standard forms (with completion of such forms, when performed), by the physician or other qualified health care professional; first 30 minutes, face-to-face with the patient, family member(s), and/or surrogate | 660 | $21,964 |
| Short return visit (20+ min) | 626 | $11,679 |
| New patient visit (60+ min) | 118 | $6,703 |
| Chronic care management services with the following required elements: multiple (two or more) chronic conditions expected to last at least 12 months, or until the death of the patient, chronic conditions that place the patient at significant risk of death, acute exacerbation/decompensation, or functional decline, comprehensive care plan established, implemented, revised, or monitored; first 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month. | 480 | $1,719 |
| Assessment of and care planning for a patient with cognitive impairment, requiring an independent historian, in the office or other outpatient, home or domiciliary or rest home, with all of the following required elements: Cognition-focused evaluation including a pertinent history and examination, Medical decision making of moderate or high complexity, Functional assessment (eg, basic and instrumental activities of daily living), including decision-making capacity, Use of standardized instruments for staging of dementia (eg, functional assessment staging test [FAST], clinical dementia rating [CDR]), Medication reconciliation and review for high-risk medications, Evaluation for neuropsychiatric and behavioral symptoms, including depression, including use of standardized screening instrument(s), Evaluation of safety (eg, home), including motor vehicle operation, Identification of caregiver(s), caregiver knowledge, caregiver needs, social supports, and the willingness of caregiver to take on caregiving tasks, Development, updating or revision, or review of an Advance Care Plan, Creation of a written care plan, including initial plans to address any neuropsychiatric symptoms, neuro-cognitive symptoms, functional limitations, and referral to community resources as needed (eg, rehabilitation services, adult day programs, support groups) shared with the patient and/or caregiver with initial education and support. Typically, 60 minutes of total time is spent on the date of the encounter. | 55 | $1,220 |
| Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug | 58 | $919 |
| Smoking and tobacco use cessation counseling visit; intermediate, greater than 3 minutes up to 10 minutes | 193 | $837 |
| Interprofessional telephone/Internet/electronic health record assessment and management service provided by a consultative physician or other qualified health care professional, including a written report to the patient's treating/requesting physician or other qualified health care professional, 5 minutes or more of medical consultative time | 13 | $449 |
| Blood, occult, by fecal hemoglobin determination by immunoassay, qualitative, feces, 1-3 simultaneous determinations | 75 | $387 |
| Hemoglobin A1C level | 82 | $347 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure) | 21 | $220 |
2018
| Return visit (30+ min) | 1,152 | $31,565 |
| Advance care planning including the explanation and discussion of advance directives such as standard forms (with completion of such forms, when performed), by the physician or other qualified health care professional; first 30 minutes, face-to-face with the patient, family member(s), and/or surrogate | 659 | $25,669 |
| Short return visit (20+ min) | 826 | $17,515 |
| New patient visit (60+ min) | 113 | $9,100 |
| Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug | 247 | $4,246 |
| Chronic care management services with the following required elements: multiple (two or more) chronic conditions expected to last at least 12 months, or until the death of the patient, chronic conditions that place the patient at significant risk of death, acute exacerbation/decompensation, or functional decline, comprehensive care plan established, implemented, revised, or monitored; first 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month. | 580 | $2,560 |
| Smoking and tobacco use cessation counseling visit; intermediate, greater than 3 minutes up to 10 minutes | 242 | $1,748 |
| Pap test | 111 | $861 |
| Blood, occult, by fecal hemoglobin determination by immunoassay, qualitative, feces, 1-3 simultaneous determinations | 75 | $741 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 28 | $198 |
| Assessment of and care planning for a patient with cognitive impairment, requiring an independent historian, in the office or other outpatient, home or domiciliary or rest home, with all of the following required elements: Cognition-focused evaluation including a pertinent history and examination, Medical decision making of moderate or high complexity, Functional assessment (eg, basic and instrumental activities of daily living), including decision-making capacity, Use of standardized instruments for staging of dementia (eg, functional assessment staging test [FAST], clinical dementia rating [CDR]), Medication reconciliation and review for high-risk medications, Evaluation for neuropsychiatric and behavioral symptoms, including depression, including use of standardized screening instrument(s), Evaluation of safety (eg, home), including motor vehicle operation, Identification of caregiver(s), caregiver knowledge, caregiver needs, social supports, and the willingness of caregiver to take on caregiving tasks, Development, updating or revision, or review of an Advance Care Plan, Creation of a written care plan, including initial plans to address any neuropsychiatric symptoms, neuro-cognitive symptoms, functional limitations, and referral to community resources as needed (eg, rehabilitation services, adult day programs, support groups) shared with the patient and/or caregiver with initial education and support. Typically, 60 minutes of total time is spent on the date of the encounter. | 19 | $38 |
| Hemoglobin A1C level | 13 | $26 |
Drugs they prescribed that Part D paid
$2,156,681
Pharmacies billed $2,156,681 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,376) in 2024. At or below the middle of the specialty; the typical hematology-oncology clinician is at 5%.
1,117 generic and 244 brand-name prescriptions · $2,156,681 in drug cost · 44 antibiotic prescriptions to 30 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Tasigna | 25 | $468,076 | $18,723 |
| Imbruvica | 14 | $224,418 | $16,030 |
| Erleada | 11 | $214,741 | $19,522 |
| Keytruda | 18 | $192,557 | $10,698 |
| Darzalex Faspro | 15 | $132,467 | $8,831 |
See all 34 drugs
| Tasigna | 25 | $468,076 | $18,723 |
| Imbruvica | 14 | $224,418 | $16,030 |
| Erleada | 11 | $214,741 | $19,522 |
| Keytruda | 18 | $192,557 | $10,698 |
| Darzalex Faspro | 15 | $132,467 | $8,831 |
| Imatinib Mesylate | 18 | $27,842 | $1,547 |
| Naproxen | 21 | $1,612 | $77 |
| Atorvastatin | 126 | $1,276 | $10 |
| Fenofibrate | 34 | $1,019 | $30 |
| Metformin | 105 | $857 | $8 |
| Anastrozole | 55 | $650 | $12 |
| Amlodipine Besylate | 75 | $449 | $6 |
| Levothyroxine | 14 | $425 | $30 |
| Tamoxifen Citrate | 23 | $419 | $18 |
| Albuterol Sulfate Hfa | 22 | $392 | $18 |
| Amlodipine-Olmesartan | 11 | $365 | $33 |
| Simvastatin | 36 | $284 | $8 |
| Lisinopril | 38 | $279 | $7 |
| Hydrochlorothiazide | 49 | $232 | $5 |
| Omeprazole | 24 | $219 | $9 |
| Losartan | 15 | $193 | $13 |
| Ibuprofen | 21 | $184 | $9 |
| Hydroxyurea | 14 | $184 | $13 |
| Ondansetron | 15 | $179 | $12 |
| Alendronate | 23 | $134 | $6 |
| Sumatriptan | 15 | $122 | $8 |
| Furosemide | 11 | $106 | $10 |
| Benazepril | 11 | $96 | $9 |
| Sodium Chloride | 31 | $92 | $3 |
| Sulfamethoxazole-Trimethoprim | 16 | $64 | $4 |
| Metoprolol | 11 | $61 | $6 |
| Ondansetron | 12 | $46 | $4 |
| Dexamethasone Sodium Phosphate | 18 | $45 | $2 |
| Diphenhydramine | 21 | $41 | $2 |
Year by year
| 2024 | 1,376 | 158 | 0% (0) | 18% | $2,156,681 |
| 2023 | 1,755 | 183 | None | None | $3,506,640 |
| 2022 | 1,641 | 170 | None | None | $2,435,280 |
| 2021 | 1,698 | 161 | None | None | $2,004,080 |
| 2020 | 1,431 | 161 | 0% (0) | 23% | $1,901,155 |
| 2019 | 1,468 | 168 | None | 30% | $2,814,674 |
| 2018 | 1,511 | 174 | 2% (29) | None | $2,831,220 |
| 2017 | 1,620 | 182 | None | 25% | $2,592,228 |
| 2016 | 2,188 | 224 | None | 28% | $2,564,839 |
| 2015 | 1,856 | 199 | 1% (18) | None | $2,080,277 |
| 2014 | 1,429 | 195 | 2% (25) | None | $1,555,942 |
| 2013 | 1,504 | 193 | 2% (30) | None | $1,241,925 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 45 drugs
| Nplate | 24 | $630,805 | $26,284 |
| Imbruvica | 27 | $426,919 | $15,812 |
| Tasigna | 21 | $425,887 | $20,280 |
| Darzalex Faspro | 25 | $297,121 | $11,885 |
| Keytruda | 24 | $287,650 | $11,985 |
| Avastin | 11 | $152,326 | $13,848 |
| Gazyva | 15 | $121,083 | $8,072 |
| Velcade | 12 | $81,259 | $6,772 |
| Procrit | 18 | $79,287 | $4,405 |
| Xgeva | 13 | $39,409 | $3,031 |
| Fulphila | 11 | $35,434 | $3,221 |
| Zoledronic Acid | 28 | $13,127 | $469 |
| Imatinib Mesylate | 20 | $12,129 | $606 |
| Eliquis | 12 | $8,622 | $719 |
| Fosaprepitant Dimeglumine | 33 | $3,544 | $107 |
| Atorvastatin | 113 | $2,301 | $20 |
| Amlodipine Besylate | 104 | $2,250 | $22 |
| Anastrozole | 51 | $1,427 | $28 |
| Metformin | 79 | $1,156 | $15 |
| Tamoxifen Citrate | 32 | $1,027 | $32 |
| Lisinopril | 65 | $722 | $11 |
| Simvastatin | 36 | $617 | $17 |
| Albuterol Sulfate Hfa | 16 | $561 | $35 |
| Dexamethasone Sodium Phosphate | 65 | $490 | $8 |
| Sodium Chloride | 80 | $477 | $6 |
| Fenofibrate | 15 | $476 | $32 |
| Losartan | 17 | $432 | $25 |
| Pantoprazole | 21 | $395 | $19 |
| Benazepril | 21 | $380 | $18 |
| Ondansetron | 14 | $373 | $27 |
| Omeprazole | 31 | $336 | $11 |
| Levothyroxine | 22 | $278 | $13 |
| Atenolol | 14 | $220 | $16 |
| Hydroxyurea | 12 | $188 | $16 |
| Gemfibrozil | 11 | $187 | $17 |
| Hydrochlorothiazide | 38 | $174 | $5 |
| Allopurinol | 11 | $173 | $16 |
| Fluticasone Propionate | 13 | $148 | $11 |
| Esomeprazole Magnesium | 11 | $134 | $12 |
| Diphenhydramine | 44 | $114 | $3 |
| Famotidine | 50 | $76 | $2 |
| Dextrose in Water | 13 | $57 | $4 |
| Heparin | 29 | $53 | $2 |
| Ondansetron | 18 | $53 | $3 |
| Famotidine | 11 | $45 | $4 |
2022: 43 drugs
| Imbruvica | 34 | $520,985 | $15,323 |
| Tasigna | 16 | $263,230 | $16,452 |
| Opdivo | 13 | $191,431 | $14,725 |
| Darzalex | 15 | $144,682 | $9,645 |
| Procrit | 33 | $131,189 | $3,975 |
| Velcade | 19 | $109,157 | $5,745 |
| Xgeva | 13 | $35,475 | $2,729 |
| Trulicity | 11 | $14,992 | $1,363 |
| Eliquis | 17 | $11,514 | $677 |
| Fosaprepitant Dimeglumine | 28 | $11,096 | $396 |
| Zoledronic Acid | 17 | $7,481 | $440 |
| Atorvastatin | 108 | $1,772 | $16 |
| Tamoxifen Citrate | 52 | $1,653 | $32 |
| Metformin | 80 | $845 | $11 |
| Albuterol Sulfate Hfa | 18 | $822 | $46 |
| Amlodipine Besylate | 95 | $807 | $8 |
| Levothyroxine | 32 | $644 | $20 |
| Simvastatin | 51 | $621 | $12 |
| Lisinopril | 66 | $598 | $9 |
| Risedronate | 13 | $567 | $44 |
| Fenofibrate | 16 | $512 | $32 |
| Hydroxyurea | 16 | $491 | $31 |
| Anastrozole | 31 | $465 | $15 |
| Ondansetron | 15 | $462 | $31 |
| Dexamethasone Sodium Phosphate | 39 | $370 | $9 |
| Atenolol | 26 | $360 | $14 |
| Potassium Chloride | 14 | $332 | $24 |
| Allopurinol | 20 | $313 | $16 |
| Benazepril | 18 | $312 | $17 |
| Triamterene-Hydrochlorothiazid | 19 | $297 | $16 |
| Omeprazole | 27 | $274 | $10 |
| Losartan | 22 | $260 | $12 |
| Ibuprofen | 15 | $216 | $14 |
| Alendronate | 14 | $214 | $15 |
| Tamsulosin | 20 | $151 | $8 |
| Furosemide | 14 | $131 | $9 |
| Hydrochlorothiazide | 39 | $118 | $3 |
| Naproxen | 19 | $107 | $6 |
| Diphenhydramine | 28 | $107 | $4 |
| Heparin | 20 | $91 | $5 |
| Famotidine | 36 | $67 | $2 |
| Gemfibrozil | 12 | $66 | $5 |
| Ondansetron | 13 | $55 | $4 |
2021: 51 drugs
| Imbruvica | 18 | $323,345 | $17,964 |
| Tasigna | 21 | $317,416 | $15,115 |
| Opdivo | 21 | $302,963 | $14,427 |
| Darzalex | 26 | $274,333 | $10,551 |
| Keytruda | 12 | $117,547 | $9,796 |
| Sandostatin Lar Depot | 14 | $88,258 | $6,304 |
| Xgeva | 25 | $63,019 | $2,521 |
| Velcade | 12 | $58,098 | $4,842 |
| Prolia | 16 | $21,308 | $1,332 |
| Fulvestrant | 13 | $6,859 | $528 |
| Zoledronic Acid | 19 | $5,452 | $287 |
| Linzess | 11 | $5,005 | $455 |
| Vinorelbine | 13 | $3,298 | $254 |
| Tamoxifen Citrate | 57 | $2,407 | $42 |
| Risedronate | 11 | $1,687 | $153 |
| Atorvastatin | 93 | $1,346 | $14 |
| Levothyroxine | 48 | $1,138 | $24 |
| Albuterol Sulfate Hfa | 22 | $1,095 | $50 |
| Metformin | 85 | $757 | $9 |
| Lisinopril | 69 | $717 | $10 |
| Hydroxyurea | 25 | $710 | $28 |
| Amlodipine Besylate | 83 | $639 | $8 |
| Fenofibrate | 14 | $581 | $42 |
| Simvastatin | 51 | $570 | $11 |
| Anastrozole | 23 | $532 | $23 |
| Triamterene-Hydrochlorothiazid | 21 | $448 | $21 |
| Losartan | 28 | $384 | $14 |
| Solu-Cortef | 11 | $364 | $33 |
| Ibuprofen | 29 | $307 | $11 |
| Omeprazole | 33 | $284 | $9 |
| Enalapril Maleate | 12 | $276 | $23 |
| Benazepril | 15 | $235 | $16 |
| Fluticasone Propionate | 15 | $225 | $15 |
| Allopurinol | 17 | $220 | $13 |
| Meclizine | 12 | $205 | $17 |
| Ondansetron | 18 | $183 | $10 |
| Dexamethasone Sodium Phosphate | 15 | $159 | $11 |
| Hydralazine | 13 | $159 | $12 |
| Naproxen | 21 | $157 | $7 |
| Latanoprost | 13 | $136 | $10 |
| Pravastatin | 13 | $119 | $9 |
| Atenolol | 11 | $93 | $8 |
| Diphenhydramine | 22 | $86 | $4 |
| Ondansetron | 16 | $81 | $5 |
| Hydrochlorothiazide | 30 | $77 | $3 |
| Tamsulosin | 11 | $77 | $7 |
| Furosemide | 14 | $71 | $5 |
| Famotidine | 30 | $52 | $2 |
| Dexamethasone Sodium Phosphate | 15 | $51 | $3 |
| Heparin | 13 | $29 | $2 |
| Meloxicam | 11 | $21 | $2 |
2020: 41 drugs
| Opdivo | 57 | $786,583 | $13,800 |
| Imbruvica | 14 | $206,594 | $14,757 |
| Tasigna | 12 | $180,732 | $15,061 |
| Darzalex | 15 | $171,105 | $11,407 |
| Keytruda | 17 | $162,078 | $9,534 |
| Xgeva | 19 | $44,357 | $2,335 |
| Prolia | 20 | $24,312 | $1,216 |
| Eliquis | 11 | $5,499 | $500 |
| Wixela Inhub | 12 | $2,965 | $247 |
| Tamoxifen Citrate | 69 | $2,886 | $42 |
| Hydroxyurea | 22 | $1,363 | $62 |
| Zoledronic Acid | 25 | $1,253 | $50 |
| Levothyroxine | 52 | $895 | $17 |
| Atorvastatin | 62 | $786 | $13 |
| Anastrozole | 22 | $743 | $34 |
| Enalapril Maleate | 20 | $474 | $24 |
| Metformin | 47 | $461 | $10 |
| Simvastatin | 37 | $424 | $11 |
| Fenofibrate | 11 | $410 | $37 |
| Lisinopril | 50 | $390 | $8 |
| Amlodipine Besylate | 54 | $335 | $6 |
| Allopurinol | 19 | $300 | $16 |
| Omeprazole | 36 | $235 | $7 |
| Potassium Chloride | 13 | $225 | $17 |
| Triamterene-Hydrochlorothiazid | 15 | $225 | $15 |
| Losartan | 19 | $212 | $11 |
| Ibuprofen | 17 | $209 | $12 |
| Metoprolol | 24 | $187 | $8 |
| Prednisone | 20 | $175 | $9 |
| Naproxen | 19 | $173 | $9 |
| Pantoprazole | 14 | $141 | $10 |
| Benazepril | 11 | $135 | $12 |
| Hydrochlorothiazide | 25 | $125 | $5 |
| Tamsulosin | 13 | $116 | $9 |
| Ondansetron | 17 | $102 | $6 |
| Glipizide | 11 | $92 | $8 |
| Diphenhydramine | 15 | $59 | $4 |
| Paroxetine | 11 | $54 | $5 |
| Sodium Chloride | 18 | $41 | $2 |
| Furosemide | 13 | $40 | $3 |
| Famotidine | 15 | $26 | $2 |
2019: 40 drugs
| Opdivo | 92 | $890,282 | $9,677 |
| Keytruda | 30 | $283,456 | $9,449 |
| Darzalex | 14 | $194,829 | $13,916 |
| Imbruvica | 15 | $192,360 | $12,824 |
| Tasigna | 12 | $174,294 | $14,524 |
| Jakafi | 12 | $154,846 | $12,904 |
| Herceptin | 19 | $94,939 | $4,997 |
| Prolia | 17 | $20,319 | $1,195 |
| Tamoxifen Citrate | 67 | $2,322 | $35 |
| Hydroxyurea | 40 | $1,497 | $37 |
| Paclitaxel | 13 | $1,466 | $113 |
| Carboplatin | 22 | $1,204 | $55 |
| Potassium Chloride | 12 | $866 | $72 |
| Atorvastatin | 61 | $842 | $14 |
| Anastrozole | 20 | $797 | $40 |
| Levothyroxine | 48 | $708 | $15 |
| Enalapril Maleate | 25 | $464 | $19 |
| Sodium Chloride | 62 | $390 | $6 |
| Simvastatin | 34 | $282 | $8 |
| Gabapentin | 17 | $266 | $16 |
| Amlodipine Besylate | 43 | $253 | $6 |
| Metformin | 41 | $239 | $6 |
| Lisinopril | 32 | $209 | $7 |
| Triamterene-Hydrochlorothiazid | 12 | $191 | $16 |
| Ondansetron | 18 | $190 | $11 |
| Omeprazole | 30 | $186 | $6 |
| Allopurinol | 12 | $178 | $15 |
| Dexamethasone Sodium Phosphate | 40 | $148 | $4 |
| Benazepril | 18 | $145 | $8 |
| Naproxen | 24 | $140 | $6 |
| Metoprolol | 16 | $127 | $8 |
| Hydrochlorothiazide | 24 | $125 | $5 |
| Atenolol | 19 | $103 | $5 |
| Carvedilol | 14 | $103 | $7 |
| Diphenhydramine | 36 | $93 | $3 |
| Cephalexin | 11 | $92 | $8 |
| Pantoprazole | 13 | $83 | $6 |
| Ondansetron | 13 | $74 | $6 |
| Glipizide | 13 | $65 | $5 |
| Famotidine | 21 | $43 | $2 |
2018: 42 drugs
| Opdivo | 115 | $939,270 | $8,168 |
| Keytruda | 44 | $415,424 | $9,441 |
| Imbruvica | 20 | $257,237 | $12,862 |
| Darzalex | 12 | $185,564 | $15,464 |
| Tasigna | 11 | $147,935 | $13,449 |
| Sandostatin Lar Depot | 20 | $122,421 | $6,121 |
| Zytiga | 11 | $114,596 | $10,418 |
| Prolia | 12 | $13,942 | $1,162 |
| Zoledronic Acid | 18 | $7,312 | $406 |
| Anastrozole | 41 | $1,455 | $35 |
| Tamoxifen Citrate | 49 | $1,371 | $28 |
| Hydroxyurea | 41 | $1,302 | $32 |
| Potassium Chloride | 26 | $773 | $30 |
| Ventolin Hfa | 14 | $751 | $54 |
| Levothyroxine | 35 | $573 | $16 |
| Enalapril Maleate | 44 | $556 | $13 |
| Simvastatin | 63 | $503 | $8 |
| Gabapentin | 16 | $476 | $30 |
| Pravastatin | 12 | $438 | $37 |
| Atorvastatin | 39 | $395 | $10 |
| Diclofenac | 13 | $352 | $27 |
| Lisinopril | 36 | $274 | $8 |
| Triamterene-Hydrochlorothiazid | 23 | $260 | $11 |
| Prednisone | 27 | $247 | $9 |
| Allopurinol | 14 | $221 | $16 |
| Ranitidine | 12 | $204 | $17 |
| Amlodipine Besylate | 31 | $200 | $6 |
| Losartan | 29 | $191 | $7 |
| Hydrochlorothiazide | 31 | $180 | $6 |
| Benazepril | 20 | $178 | $9 |
| Ondansetron | 13 | $160 | $12 |
| Sodium Chloride | 20 | $158 | $8 |
| Montelukast | 12 | $155 | $13 |
| Atenolol | 23 | $152 | $7 |
| Omeprazole | 16 | $129 | $8 |
| Carvedilol | 12 | $125 | $10 |
| Dexamethasone Sodium Phosphate | 19 | $105 | $6 |
| Metformin | 28 | $96 | $3 |
| Ondansetron | 14 | $93 | $7 |
| Glipizide | 11 | $57 | $5 |
| Furosemide | 14 | $47 | $3 |
| Diphenhydramine | 11 | $31 | $3 |
2017: 47 drugs
| Imbruvica | 34 | $400,752 | $11,787 |
| Rituxan | 12 | $308,478 | $25,706 |
| Opdivo | 17 | $274,455 | $16,144 |
| Keytruda | 27 | $246,988 | $9,148 |
| Jakafi | 13 | $156,405 | $12,031 |
| Revlimid | 11 | $147,310 | $13,392 |
| Neulasta | 18 | $103,136 | $5,730 |
| Xgeva | 32 | $67,544 | $2,111 |
| Faslodex | 18 | $33,654 | $1,870 |
| Zoledronic Acid | 17 | $4,514 | $266 |
| Tamoxifen Citrate | 58 | $2,423 | $42 |
| Humulin N | 13 | $1,970 | $152 |
| Anastrozole | 40 | $1,641 | $41 |
| Hydroxyurea | 41 | $1,093 | $27 |
| Paclitaxel | 13 | $1,076 | $83 |
| Levothyroxine | 57 | $1,056 | $19 |
| Fenofibrate | 21 | $825 | $39 |
| Pravastatin | 32 | $755 | $24 |
| Bicalutamide | 14 | $571 | $41 |
| Enalapril Maleate | 29 | $512 | $18 |
| Simvastatin | 62 | $393 | $6 |
| Dexamethasone Sodium Phosphate | 55 | $355 | $6 |
| Triamterene-Hydrochlorothiazid | 29 | $355 | $12 |
| Atorvastatin | 20 | $352 | $18 |
| Lisinopril | 59 | $288 | $5 |
| Amlodipine Besylate | 47 | $273 | $6 |
| Sodium Chloride | 21 | $270 | $13 |
| Metformin | 50 | $257 | $5 |
| Ranitidine | 14 | $238 | $17 |
| Carvedilol | 15 | $201 | $13 |
| Benazepril | 23 | $200 | $9 |
| Losartan | 21 | $196 | $9 |
| Hydrochlorothiazide | 36 | $192 | $5 |
| Ondansetron | 22 | $186 | $8 |
| Gabapentin | 19 | $184 | $10 |
| Atenolol | 21 | $147 | $7 |
| Potassium Chloride | 12 | $145 | $12 |
| Metoprolol | 20 | $145 | $7 |
| Clopidogrel | 11 | $132 | $12 |
| Omeprazole | 12 | $117 | $10 |
| Warfarin | 13 | $107 | $8 |
| Alendronate | 18 | $106 | $6 |
| Prednisone | 12 | $85 | $7 |
| Diphenhydramine | 28 | $57 | $2 |
| Clonidine | 14 | $53 | $4 |
| Citalopram Hbr | 11 | $33 | $3 |
| Famotidine | 12 | $18 | $2 |
2016: 60 drugs
| Opdivo | 24 | $287,453 | $11,977 |
| Xtandi | 22 | $201,109 | $9,141 |
| Neulasta | 33 | $198,149 | $6,005 |
| Revlimid | 16 | $187,907 | $11,744 |
| Zytiga | 19 | $165,513 | $8,711 |
| Tasigna | 25 | $161,656 | $6,466 |
| Ibrance | 14 | $148,889 | $10,635 |
| Sandostatin Lar Depot | 17 | $87,792 | $5,164 |
| Xgeva | 32 | $63,430 | $1,982 |
| Faslodex | 29 | $54,855 | $1,892 |
| Cyramza | 12 | $46,472 | $3,873 |
| Lupron Depot | 20 | $27,864 | $1,393 |
| Emend | 39 | $16,996 | $436 |
| Leukeran | 15 | $11,118 | $741 |
| Exemestane | 16 | $5,048 | $316 |
| Vinorelbine | 18 | $2,203 | $122 |
| Tamoxifen Citrate | 53 | $2,149 | $41 |
| Anastrozole | 84 | $2,064 | $25 |
| Hydroxyurea | 37 | $1,549 | $42 |
| Levothyroxine | 81 | $1,398 | $17 |
| Paclitaxel | 16 | $1,325 | $83 |
| Carboplatin | 13 | $1,092 | $84 |
| Enalapril Maleate | 35 | $1,037 | $30 |
| Bicalutamide | 27 | $779 | $29 |
| Felodipine Er | 16 | $601 | $38 |
| Valsartan | 14 | $595 | $42 |
| Metformin | 61 | $560 | $9 |
| Atorvastatin | 27 | $560 | $21 |
| Pravastatin | 21 | $555 | $26 |
| Ondansetron | 17 | $542 | $32 |
| Triamterene-Hydrochlorothiazid | 42 | $531 | $13 |
| Gabapentin | 12 | $490 | $41 |
| Prochlorperazine Maleate | 17 | $487 | $29 |
| Warfarin | 52 | $463 | $9 |
| Omeprazole | 30 | $460 | $15 |
| Sodium Chloride | 50 | $390 | $8 |
| Letrozole | 12 | $379 | $32 |
| Prednisone | 52 | $354 | $7 |
| Lisinopril | 73 | $343 | $5 |
| Simvastatin | 51 | $303 | $6 |
| Allopurinol | 15 | $267 | $18 |
| Amlodipine Besylate | 58 | $229 | $4 |
| Losartan | 23 | $226 | $10 |
| Dexamethasone Sodium Phosphate | 49 | $214 | $4 |
| Benazepril | 24 | $205 | $9 |
| Potassium Chloride | 17 | $204 | $12 |
| Ibuprofen | 17 | $204 | $12 |
| Pantoprazole | 24 | $170 | $7 |
| Metoprolol | 22 | $169 | $8 |
| Hydrochlorothiazide | 44 | $152 | $3 |
| Ondansetron | 13 | $139 | $11 |
| Clonidine | 26 | $134 | $5 |
| Alendronate | 20 | $127 | $6 |
| Furosemide | 27 | $127 | $5 |
| Carvedilol | 15 | $124 | $8 |
| Diphenhydramine | 37 | $86 | $2 |
| Ciprofloxacin | 12 | $79 | $7 |
| Atenolol | 17 | $74 | $4 |
| Magnesium Sulfate | 12 | $39 | $3 |
| Glipizide | 11 | $18 | $2 |
2015: 48 drugs
| Revlimid | 25 | $262,077 | $10,483 |
| Zytiga | 30 | $238,072 | $7,936 |
| Xtandi | 23 | $203,152 | $8,833 |
| Afinitor | 16 | $165,557 | $10,347 |
| Tasigna | 21 | $111,107 | $5,291 |
| Xgeva | 56 | $105,747 | $1,888 |
| Neulasta | 16 | $95,876 | $5,992 |
| Faslodex | 22 | $41,957 | $1,907 |
| Lupron Depot | 20 | $23,580 | $1,179 |
| Leukeran | 29 | $14,932 | $515 |
| Prolia | 12 | $11,361 | $947 |
| Exemestane | 23 | $9,817 | $427 |
| Zoledronic Acid | 15 | $4,112 | $274 |
| Hydroxyurea | 70 | $2,819 | $40 |
| Leucovorin | 20 | $2,608 | $130 |
| Anastrozole | 71 | $1,941 | $27 |
| Tamoxifen Citrate | 48 | $1,698 | $35 |
| Levothyroxine | 77 | $1,405 | $18 |
| Bicalutamide | 27 | $1,085 | $40 |
| Enalapril Maleate | 46 | $1,066 | $23 |
| Ibandronate | 13 | $928 | $71 |
| Atorvastatin | 34 | $546 | $16 |
| Prednisone | 64 | $539 | $8 |
| Warfarin | 55 | $526 | $10 |
| Triamterene-Hydrochlorothiazid | 38 | $488 | $13 |
| Simvastatin | 55 | $478 | $9 |
| Fluorouracil | 21 | $461 | $22 |
| Dexamethasone | 20 | $459 | $23 |
| Digoxin | 13 | $438 | $34 |
| Ondansetron | 47 | $353 | $8 |
| Felodipine Er | 13 | $346 | $27 |
| Alendronate | 38 | $325 | $9 |
| Losartan | 21 | $232 | $11 |
| Potassium Chloride | 12 | $232 | $19 |
| Lisinopril | 41 | $222 | $5 |
| Verapamil Er | 12 | $200 | $17 |
| Metoprolol | 25 | $190 | $8 |
| Letrozole | 25 | $171 | $7 |
| Metformin | 35 | $161 | $5 |
| Dexamethasone Sodium Phosphate | 30 | $148 | $5 |
| Allopurinol | 12 | $143 | $12 |
| Amlodipine Besylate | 39 | $126 | $3 |
| Omeprazole | 13 | $117 | $9 |
| Pantoprazole | 14 | $107 | $8 |
| Atenolol | 16 | $104 | $7 |
| Furosemide | 11 | $50 | $5 |
| Clonidine | 13 | $40 | $3 |
| Diphenhydramine | 18 | $33 | $2 |
2014: 41 drugs
| Revlimid | 29 | $272,647 | $9,402 |
| Afinitor | 12 | $150,795 | $12,566 |
| Inlyta | 16 | $150,578 | $9,411 |
| Tarceva | 22 | $134,499 | $6,114 |
| Xtandi | 14 | $115,729 | $8,266 |
| Zytiga | 15 | $109,932 | $7,329 |
| Tasigna | 18 | $100,310 | $5,573 |
| Votrient | 11 | $85,910 | $7,810 |
| Neupogen | 17 | $59,735 | $3,514 |
| Xgeva | 24 | $42,851 | $1,785 |
| Lupron Depot | 26 | $29,552 | $1,137 |
| Faslodex | 11 | $20,023 | $1,820 |
| Exemestane | 32 | $9,479 | $296 |
| Leukeran | 13 | $7,472 | $575 |
| Anastrozole | 85 | $4,124 | $49 |
| Lyrica | 12 | $2,332 | $194 |
| Tamoxifen Citrate | 72 | $2,159 | $30 |
| Hydroxyurea | 52 | $2,058 | $40 |
| Niacin Er | 11 | $1,806 | $164 |
| Bicalutamide | 19 | $699 | $37 |
| Enalapril Maleate | 37 | $677 | $18 |
| Digoxin | 17 | $633 | $37 |
| Dexamethasone | 39 | $629 | $16 |
| Levothyroxine | 37 | $596 | $16 |
| Megestrol Acetate | 13 | $571 | $44 |
| Triamterene-Hydrochlorothiazid | 34 | $565 | $17 |
| Alendronate | 44 | $513 | $12 |
| Letrozole | 23 | $494 | $21 |
| Atorvastatin | 19 | $476 | $25 |
| Gabapentin | 18 | $334 | $19 |
| Warfarin | 43 | $309 | $7 |
| Simvastatin | 41 | $303 | $7 |
| Prednisone | 22 | $297 | $13 |
| Pantoprazole | 20 | $225 | $11 |
| Lisinopril | 36 | $206 | $6 |
| Losartan | 16 | $186 | $12 |
| Metformin | 29 | $177 | $6 |
| Verapamil Er | 11 | $175 | $16 |
| Ondansetron | 13 | $142 | $11 |
| Amlodipine Besylate | 24 | $132 | $6 |
| Atenolol | 21 | $130 | $6 |
2013: 43 drugs
| Revlimid | 43 | $427,052 | $9,931 |
| Votrient | 17 | $120,717 | $7,101 |
| Tarceva | 15 | $82,581 | $5,505 |
| Neupogen | 16 | $66,944 | $4,184 |
| Faslodex | 26 | $46,819 | $1,801 |
| Lupron Depot | 30 | $33,803 | $1,127 |
| Xgeva | 16 | $26,590 | $1,662 |
| Arimidex | 12 | $5,357 | $446 |
| Lyrica | 23 | $3,749 | $163 |
| Exemestane | 19 | $3,526 | $186 |
| Anastrozole | 73 | $2,784 | $38 |
| Ondansetron | 18 | $2,055 | $114 |
| Letrozole | 43 | $1,323 | $31 |
| Tamoxifen Citrate | 50 | $1,209 | $24 |
| Amantadine | 12 | $1,186 | $99 |
| Gabapentin | 37 | $1,099 | $30 |
| Amlodipine Besylate-Benazepril | 11 | $790 | $72 |
| Atorvastatin | 16 | $775 | $48 |
| Albuterol Sulfate | 11 | $757 | $69 |
| Warfarin | 52 | $648 | $12 |
| Alendronate | 38 | $523 | $14 |
| Triamterene-Hctz | 34 | $511 | $15 |
| Potassium Chloride | 18 | $499 | $28 |
| Levothyroxine | 52 | $470 | $9 |
| Enalapril Maleate | 43 | $447 | $10 |
| Dexamethasone | 35 | $441 | $13 |
| Simvastatin | 41 | $354 | $9 |
| Levofloxacin | 12 | $351 | $29 |
| Prochlorperazine Maleate | 19 | $307 | $16 |
| Prednisone | 40 | $278 | $7 |
| Metformin | 28 | $265 | $9 |
| Tamsulosin | 15 | $264 | $18 |
| Diphenoxylate-Atropine | 15 | $241 | $16 |
| Glyburide | 13 | $226 | $17 |
| Verapamil Er | 12 | $180 | $15 |
| Atenolol | 30 | $172 | $6 |
| Triamterene-Hydrochlorothiazid | 11 | $169 | $15 |
| Amlodipine Besylate | 30 | $165 | $6 |
| Losartan | 16 | $163 | $10 |
| Paroxetine | 11 | $154 | $14 |
| Lisinopril | 17 | $139 | $8 |
| Omeprazole | 13 | $131 | $10 |
| Zolpidem | 13 | $81 | $6 |
Money from drug and device companies
$5,151 in 2025
| 2025 | 54 | 220 | None | $5,151 |
| 2024 | 32 | 174 | $6,508 | $10,660 |
| 2023 | 21 | 147 | $2,498 | $7,852 |
| 2022 | 25 | 109 | None | $2,663 |
| 2021 | 19 | 79 | $3,100 | $5,370 |
| 2020 | 17 | 54 | $2,620 | $4,205 |
| 2019 | 7 | 32 | $12,153 | $14,689 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Janssen Biotech | Erleada | $710 | 37 payments
|
| Incyte | Monjuvi | $486 | 11 payments
|
| AstraZeneca Pharmaceuticals LP | Imfinzi | $436 | 18 payments
|
| Pfizer | Adcetris | $326 | 14 payments
|
| Abbvie | Imbruvica | $208 | 8 payments
|
| Takeda Pharmaceuticals U.S.A. | Fruzaqla | $198 | 9 payments
|
See all 211 published payments
| Janssen Biotech | Meals · 2025-12-17 | Darzalex | $27 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-12-16 | Enhertu | $27 |
| Taiho Oncology | Meals · 2025-12-16 | Lonsurf | $25 |
| PharmaEssentia USA | Meals · 2025-12-15 | Besremi | $33 |
| Janssen Biotech | Meals · 2025-12-11 | Darzalex | $12 |
| Sobi | Meals · 2025-12-11 | Vonjo | $27 |
| Array Biopharma | Meals · 2025-12-10 | Braftovi | $15 |
| Janssen Biotech | Meals · 2025-12-09 | Darzalex | $11 |
| Abbvie | Meals · 2025-12-09 | Emrelis | $27 |
| Astellas Pharma Global Development | Meals · 2025-12-04 | Veozah | $21 |
| Janssen Biotech | Meals · 2025-12-03 | Darzalex | $14 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-12-03 | Tagrisso | $33 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-12-02 | Lynparza | $14 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-12-02 | Nubeqa | $10 |
| Incyte | Meals · 2025-12-01 | Monjuvi | $24 |
| Novartis Pharmaceuticals | Meals · 2025-11-25 | Fabhalta | $30 |
| Coherus Oncology | Meals · 2025-11-20 | Loqtorzi | $24 |
| Janssen Biotech | Meals · 2025-11-19 | Darzalex | $12 |
| Janssen Biotech | Meals · 2025-11-18 | Rybrevant | $13 |
| Pfizer | Meals · 2025-11-12 | Adcetris | $38 |
| Janssen Biotech | Meals · 2025-11-11 | Carvykti | $16 |
| GlaxoSmithKline | Meals · 2025-11-11 | Jemperli | $19 |
| Spectrum Pharmaceuticals | Meals · 2025-11-11 | Rolvedon | $27 |
| Caris MPI | Meals · 2025-11-10 | Mi Cancer Seek | $18 |
| Janssen Biotech | Meals · 2025-11-09 | Erleada | $17 |
| Kyowa Kirin | Meals · 2025-11-06 | Poteligeo | $18 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-11-05 | Calquence | $26 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-11-04 | Iclusig | $11 |
| Eisai | Meals · 2025-11-04 | Lenvima | $31 |
| Janssen Biotech | Meals · 2025-11-03 | Talvey | $11 |
| Daiichi Sankyo | Meals · 2025-10-27 | Datroway | $25 |
| Pharmacosmos Therapeutics | Meals · 2025-10-23 | Monoferric | $24 |
| Lilly USA | Meals · 2025-10-21 | Verzenio | $28 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-10-21 | Fruzaqla | $25 |
| Rigel Pharmaceuticals | Meals · 2025-10-20 | Tavalisse | $30 |
| Genmab U.S. | Meals · 2025-10-16 | Epkinly | $30 |
| Janssen Biotech | Meals · 2025-10-15 | Erleada | $15 |
| GlaxoSmithKline | Meals · 2025-10-15 | Jemperli | $19 |
| Abbvie | Meals · 2025-10-15 | Imbruvica | $24 |
| Pfizer | Meals · 2025-10-14 | Elrexfio | $30 |
| Abbvie | Meals · 2025-10-13 | Elahere | $30 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-10-08 | None | $14 |
| GlaxoSmithKline | Meals · 2025-10-07 | Ojjaara | $32 |
| Kite Pharma | Meals · 2025-10-06 | Yescarta | $16 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-10-06 | Nubeqa | $9 |
| Janssen Biotech | Meals · 2025-10-01 | Darzalex | $12 |
| Incyte | Meals · 2025-09-30 | Jakafi | $24 |
| Incyte | Education · 2025-09-30 | None | $93 |
| Apellis Pharmaceuticals | Meals · 2025-09-29 | Empaveli | $27 |
| Abbvie | Meals · 2025-09-25 | Venclexta | $32 |
| BeOne Medicines USA | Meals · 2025-09-23 | Brukinsa | $38 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-23 | Imfinzi | $31 |
| Iovance Biotherapeutics | Meals · 2025-09-22 | Amtagvi | $10 |
| Pfizer | Meals · 2025-09-18 | Ibrance | $23 |
| Janssen Biotech | Meals · 2025-09-17 | Erleada | $37 |
| Pfizer | Meals · 2025-09-15 | Elrexfio | $35 |
| Novartis Pharmaceuticals | Meals · 2025-09-11 | Lutathera | $32 |
| Taiho Oncology | Meals · 2025-09-09 | Lonsurf | $26 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-09-08 | Nubeqa | $11 |
| Sobi | Meals · 2025-09-04 | Vonjo | $17 |
| PharmaEssentia USA | Meals · 2025-09-04 | Besremi | $31 |
| Janssen Biotech | Meals · 2025-09-02 | Darzalex | $12 |
| Genzyme | Meals · 2025-09-02 | Wayrilz | $28 |
| GlaxoSmithKline | Meals · 2025-08-28 | Ojjaara | $14 |
| Janssen Biotech | Meals · 2025-08-27 | Erleada | $42 |
| Novartis Pharmaceuticals | Meals · 2025-08-26 | Fabhalta | $4 |
| Novartis Pharmaceuticals | Meals · 2025-08-26 | Fabhalta | $17 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-25 | Calquence | $32 |
| Pfizer | Meals · 2025-08-25 | Padcev | $15 |
| Janssen Biotech | Meals · 2025-08-21 | Darzalex | $11 |
| Puma Biotechnology | Meals · 2025-08-20 | Nerlynx | $28 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-08-18 | Nubeqa | $12 |
| Incyte | Meals · 2025-08-18 | Monjuvi | $23 |
| Regeneron Healthcare Solutions | Meals · 2025-08-14 | Libtayo | $26 |
| Janssen Biotech | Meals · 2025-08-13 | Erleada | $40 |
| Stemline Therapeutics | Meals · 2025-08-12 | Orserdu | $25 |
| Celgene | Meals · 2025-08-11 | Reblozyl | $29 |
| Kyowa Kirin | Meals · 2025-08-07 | Poteligeo | $22 |
| Janssen Biotech | Meals · 2025-08-06 | Darzalex | $12 |
| Genmab U.S. | Meals · 2025-08-06 | Epkinly | $33 |
| Incyte | Meals · 2025-08-05 | Jakafi | $26 |
| Lilly USA | Meals · 2025-08-04 | Verzenio | $27 |
| GlaxoSmithKline | Meals · 2025-08-01 | Jemperli | $10 |
| Janssen Biotech | Meals · 2025-07-31 | Rybrevant | $18 |
| PharmaEssentia USA | Meals · 2025-07-30 | Besremi | $29 |
| Abbvie | Meals · 2025-07-29 | Imbruvica | $26 |
| Janssen Biotech | Meals · 2025-07-14 | Darzalex | $2 |
| Janssen Biotech | Meals · 2025-07-14 | Darzalex | $11 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-07-12 | Fruzaqla | $28 |
| Pharmacosmos Therapeutics | Meals · 2025-07-11 | Monoferric | $26 |
| Pfizer | Meals · 2025-07-10 | Elrexfio | $27 |
| Daiichi Sankyo | Meals · 2025-07-08 | Datroway | $23 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-07-08 | Enhertu | $27 |
| Incyte | Meals · 2025-07-01 | Monjuvi | $10 |
| Janssen Biotech | Meals · 2025-06-30 | Erleada | $38 |
| Incyte | Meals · 2025-06-30 | Jakafi | $4 |
| Incyte | Meals · 2025-06-30 | Jakafi | $18 |
| EMD Serono | Meals · 2025-06-26 | None | $24 |
| Array Biopharma | Meals · 2025-06-25 | Braftovi | $38 |
| Lilly USA | Meals · 2025-06-24 | Verzenio | $27 |
| Janssen Biotech | Meals · 2025-06-23 | Darzalex | $13 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-06-23 | Imfinzi | $14 |
| Fresenius Kabi USA | Meals · 2025-06-19 | None | $31 |
| Rigel Pharmaceuticals | Meals · 2025-06-17 | Tavalisse | $29 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-06-16 | Tagrisso | $16 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-06-16 | Nubeqa | $27 |
| GlaxoSmithKline | Meals · 2025-06-13 | Jemperli | $20 |
| Abbvie | Meals · 2025-06-12 | Imbruvica | $27 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-06-11 | Nubeqa | $19 |
| Taiho Oncology | Meals · 2025-06-10 | Lonsurf | $33 |
| Astellas Pharma Global Development | Meals · 2025-06-10 | Veozah | $22 |
| Accord Healthcare | Meals · 2025-06-10 | Camcevi | $14 |
| Astellas Pharma US | Meals · 2025-06-05 | Vyloy | $22 |
| Janssen Biotech | Meals · 2025-06-04 | Erleada | $31 |
| Merck Sharp & Dohme | Meals · 2025-05-29 | Keytruda | $30 |
| Stemline Therapeutics | Meals · 2025-05-29 | Orserdu | $19 |
| Regeneron Healthcare Solutions | Meals · 2025-05-28 | Libtayo | $121 |
| Apellis Pharmaceuticals | Meals · 2025-05-28 | Empaveli | $25 |
| Janssen Biotech | Meals · 2025-05-27 | Darzalex | $11 |
| Eisai | Meals · 2025-05-27 | Lenvima | $31 |
| GlaxoSmithKline | Meals · 2025-05-22 | Ojjaara | $16 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-22 | Calquence | $24 |
| Pfizer | Meals · 2025-05-21 | Xtandi | $6 |
| Pfizer | Meals · 2025-05-21 | Xtandi | $3 |
| Janssen Biotech | Meals · 2025-05-20 | Erleada | $32 |
| Genzyme | Meals · 2025-05-19 | None | $35 |
| Novartis Pharmaceuticals | Meals · 2025-05-15 | Fabhalta | $5 |
| Novartis Pharmaceuticals | Meals · 2025-05-15 | Fabhalta | $9 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-05-15 | Nubeqa | $22 |
| Novartis Pharmaceuticals | Meals · 2025-05-12 | Scemblix | $24 |
| Incyte | Meals · 2025-05-08 | Jakafi | $124 |
| Abbvie | Meals · 2025-05-07 | Venclexta | $19 |
| Alexion Pharmaceuticals | Meals · 2025-05-07 | Ultomiris | $33 |
| Janssen Biotech | Meals · 2025-05-05 | Carvykti | $24 |
| Pfizer | Meals · 2025-05-05 | Adcetris | $38 |
| Janssen Biotech | Meals · 2025-05-01 | Rybrevant | $24 |
| Janssen Biotech | Meals · 2025-05-01 | Darzalex | $14 |
| Janssen Biotech | Meals · 2025-05-01 | Erleada | $39 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-04-29 | Opdivo | $23 |
| GlaxoSmithKline | Meals · 2025-04-29 | Jemperli | $23 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-04-29 | Iclusig | $29 |
| Merck Sharp & Dohme | Meals · 2025-04-28 | Keytruda | $33 |
| Abbvie | Meals · 2025-04-24 | Elahere | $23 |
| Ge Healthcare | Meals · 2025-04-24 | None | $25 |
| Legend Biotech USA | Meals · 2025-04-23 | Carvykti | $27 |
| Celgene | Meals · 2025-04-21 | Reblozyl | $19 |
| Lilly USA | Meals · 2025-04-21 | Verzenio | $21 |
| Janssen Biotech | Meals · 2025-04-17 | Darzalex | $12 |
| Novartis Pharmaceuticals | Meals · 2025-04-16 | Fabhalta | $4 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-04-16 | Nubeqa | $14 |
| Incyte | Meals · 2025-04-15 | Monjuvi | $125 |
| Sobi | Meals · 2025-04-15 | Doptelet | $21 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-04-10 | Fruzaqla | $5 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-04-10 | Fruzaqla | $18 |
| Janssen Biotech | Meals · 2025-04-09 | Erleada | $39 |
| Geron | Meals · 2025-04-08 | Rytelo | $34 |
| Karyopharm Therapeutics | Meals · 2025-04-08 | Xpovio | $23 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-04-07 | Enhertu | $19 |
| AstraZeneca Pharmaceuticals LP | Education · 2025-04-07 | Enhertu | $7 |
| Incyte | Meals · 2025-04-04 | Jakafi | $15 |
| Seagen | Education · 2025-04-04 | None | $100 |
| Gilead Sciences | Meals · 2025-04-03 | Trodelvy | $25 |
| Pfizer | Meals · 2025-04-01 | Padcev | $25 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-03-31 | Nubeqa | $20 |
| Dendreon Pharmaceuticals | Meals · 2025-03-28 | Provenge | $30 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-03-26 | Imfinzi | $21 |
| Regeneron Healthcare Solutions | Meals · 2025-03-25 | Libtayo | $24 |
| Gilead Sciences | Meals · 2025-03-24 | None | $14 |
| Janssen Biotech | Meals · 2025-03-20 | Darzalex | $11 |
| Janssen Biotech | Meals · 2025-03-20 | Darzalex | $1 |
| Pfizer | Meals · 2025-03-18 | Ibrance | $28 |
| Pfizer | Meals · 2025-03-18 | Ibrance | $11 |
| Agios Pharmaceuticals | Meals · 2025-03-17 | Pyrukynd | $31 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-03-13 | Lynparza | $17 |
| BeiGene USA | Meals · 2025-03-12 | Tevimbra | $28 |
| Pfizer | Meals · 2025-03-12 | Bosulif | $18 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-03-11 | Imfinzi | $30 |
| Coherus Oncology | Meals · 2025-03-10 | Udenyca | $20 |
| Celgene | Meals · 2025-03-04 | Reblozyl | $27 |
| Lilly USA | Meals · 2025-02-25 | Verzenio | $19 |
| GlaxoSmithKline | Meals · 2025-02-25 | Jemperli | $29 |
| Stemline Therapeutics | Meals · 2025-02-24 | Orserdu | $40 |
| Merck Sharp & Dohme | Meals · 2025-02-19 | Welireg | $31 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-02-17 | None | $21 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-02-13 | None | $34 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-02-13 | Stivarga | $10 |
| Novartis Pharmaceuticals | Meals · 2025-02-11 | Fabhalta | $19 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-02-10 | Nubeqa | $26 |
| Taiho Oncology | Meals · 2025-02-06 | Lonsurf | $29 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-02-06 | Fruzaqla | $34 |
| Janssen Biotech | Meals · 2025-02-05 | Darzalex | $11 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-02-05 | None | $20 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-02-05 | Fruzaqla | $22 |
| Karyopharm Therapeutics | Meals · 2025-02-05 | Xpovio | $19 |
| Pfizer | Meals · 2025-02-03 | Adcetris | $29 |
| Azurity Pharmaceuticals | Meals · 2025-01-29 | Danziten | $17 |
| Janssen Biotech | Meals · 2025-01-28 | Rybrevant | $24 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-01-27 | Iclusig | $25 |
| Novartis Pharmaceuticals | Meals · 2025-01-23 | Kisqali | $8 |
| Novartis Pharmaceuticals | Meals · 2025-01-23 | Scemblix | $5 |
| Novartis Pharmaceuticals | Meals · 2025-01-23 | Scemblix | $12 |
| Lilly USA | Meals · 2025-01-21 | Verzenio | $25 |
| Array Biopharma | Meals · 2025-01-16 | Braftovi | $16 |
| Sobi | Meals · 2025-01-14 | Vonjo | $20 |
| Servier Pharmaceuticals | Meals · 2025-01-13 | None | $23 |
| Syndax Pharmaceuticals | Meals · 2025-01-09 | None | $31 |
| Janssen Biotech | Meals · 2025-01-08 | Erleada | $31 |
| SpringWorks Therapeutics | Meals · 2025-01-08 | None | $23 |
| Janssen Biotech | Meals · 2025-01-06 | Talvey | $13 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-01-06 | Calquence | $14 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-01-06 | Imfinzi | $62 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $10,660
| Novartis Pharmaceuticals | Scemblix | $2,646 | 20 payments
|
| Alexion Pharmaceuticals | Ultomiris | $2,548 | 4 payments
|
| AstraZeneca Pharmaceuticals LP | Truqap | $2,308 | 25 payments
|
| Janssen Biotech | Darzalex | $609 | 22 payments
|
| Incyte | Jakafi | $386 | 15 payments
|
| Gilead Sciences | Trodelvy | $200 | 10 payments
|
| E.R. Squibb & Sons L.L.C. | Opdivo | $196 | 9 payments
|
| Takeda Pharmaceuticals U.S.A. | Iclusig | $163 | 4 payments
|
| Astellas Pharma US | Vyloy | $162 | 5 payments
|
| Pfizer | Bosulif | $156 | 10 payments
|
| Sobi | Vonjo | $151 | 2 payments
|
| GlaxoSmithKline | Ojjaara | $148 | 2 payments
|
| Aveo Pharmaceuticals | Fotivda | $136 | 2 payments
|
| PharmaEssentia USA | Besremi | $120 | 4 payments
|
| Bayer Healthcare Pharmaceuticals | Nubeqa | $94 | 4 payments
|
| Abbvie | Venclexta | $94 | 1 payment
|
| Regeneron Healthcare Solutions | Libtayo | $55 | 2 payments
|
| Eisai | Lenvima | $53 | 2 payments
|
| Agios Pharmaceuticals | Pyrukynd | $52 | 2 payments
|
| Genzyme | Sarclisa | $51 | 2 payments
|
| Jazz Pharmaceuticals | Zepzelca | $45 | 2 payments
|
| Celgene | Pomalyst | $34 | 1 payment
|
| Lilly USA | Verzenio | $33 | 1 payment
|
| Legend Biotech USA | None | $32 | 1 payment
|
| Array Biopharma | Braftovi | $32 | 2 payments
|
| EMD Serono | None | $31 | 1 payment
|
| Ipsen Biopharmaceuticals | Onivyde | $28 | 1 payment
|
| Novocure | Optune Lua (Novottf-200t) | $24 | 1 payment
|
| Karyopharm Therapeutics | Xpovio | $21 | 1 payment
|
| Merck Sharp & Dohme | Keytruda | $19 | 1 payment
|
| BeiGene USA | Brukinsa | $17 | 1 payment
|
| Sirtex Medical | Sir-Spheres Microspheres | $17 | 1 payment
|
2023: $7,852
| AstraZeneca Pharmaceuticals LP | Imfinzi | $3,094 | 15 payments
|
| Bayer Healthcare Pharmaceuticals | Nubeqa | $2,148 | 13 payments
|
| Janssen Biotech | Imbruvica | $472 | 25 payments
|
| E.R. Squibb & Sons L.L.C. | Reblozyl | $402 | 16 payments
|
| Novartis Pharmaceuticals | Scemblix | $394 | 17 payments
|
| Incyte | Jakafi | $344 | 13 payments
|
| Genzyme | Sarclisa | $213 | 4 payments
|
| GlaxoSmithKline | Zejula | $158 | 10 payments
|
| Takeda Pharmaceuticals U.S.A. | Ninlaro | $154 | 5 payments
|
| AVEO Pharmaceuticals | Fotivda | $72 | 2 payments
|
| Pharmacyclics LLC An AbbVie | Imbruvica | $64 | 2 payments
|
| Celgene | Pomalyst | $58 | 3 payments
|
| Puma Biotechnology | None | $55 | 2 payments
|
| Amgen | Blincyto | $50 | 2 payments
|
| Astellas Pharma US | Xospata | $50 | 3 payments
|
| Genentech USA | Phesgo | $28 | 1 payment
|
| Pfizer | Bosulif | $24 | 1 payment
|
| Kite Pharma | Yescarta | $21 | 1 payment
|
| Agios Pharmaceuticals | Pyrukynd | $20 | 1 payment
|
| Sumitomo Pharma America | Orgovyx | $17 | 1 payment
|
| Foundation Medicine | None | $14 | 1 payment
|
2022: $2,663
| E.R. Squibb & Sons L.L.C. | Opdivo | $546 | 9 payments
|
| Novartis Pharmaceuticals | Kisqali | $252 | 6 payments
|
| AstraZeneca Pharmaceuticals LP | Imfinzi | $212 | 9 payments
|
| Daiichi Sankyo | Enhertu | $202 | 5 payments
|
| Incyte | Jakafi | $189 | 8 payments
|
| Janssen Biotech | Imbruvica | $176 | 18 payments
|
| Takeda Pharmaceuticals U.S.A. | Ninlaro | $153 | 5 payments
|
| GlaxoSmithKline | Zejula | $151 | 11 payments
|
| Genzyme | Elitek | $105 | 5 payments
|
| Sanofi-Aventis U.S. | Elitek | $100 | 1 payment
|
| Amgen | Nplate | $98 | 4 payments
|
| Sobi | Doptelet | $57 | 2 payments
|
| Bayer HealthCare Pharmaceuticals | Nubeqa | $50 | 2 payments
|
| Pharmacyclics LLC an AbbVie | Imbruvica | $45 | 2 payments
|
| EMD Serono | None | $44 | 2 payments
|
| AVEO Pharmaceuticals | Fotivda | $44 | 2 payments
|
| Gilead Sciences | Trodelvy | $42 | 2 payments
|
| Pfizer | Bosulif | $34 | 2 payments
|
| Celgene | Reblozyl | $32 | 2 payments
|
| BeiGene USA | Brukinsa | $30 | 1 payment
|
| Astellas Pharma US | Xtandi | $29 | 2 payments
|
| PharmaEssentia USA | Besremi | $23 | 1 payment
|
| Kite Pharma | None | $23 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Gilotrif | $15 | 1 payment
|
| Myovant Sciences | Orgovyx | $13 | 1 payment
|
2021: $5,370
| Pfizer | Bosulif | $1,855 | 8 payments
|
| Coherus Biosciences | None | $1,350 | 1 payment
|
| Novartis Pharmaceuticals | Kisqali | $1,296 | 24 payments
|
| Amgen | Kyprolis | $136 | 8 payments
|
| Incyte | Jakafi | $109 | 5 payments
|
| Dova Pharmaceuticals | Doptelet | $96 | 5 payments
|
| AstraZeneca Pharmaceuticals LP | Lynparza | $82 | 4 payments
|
| Bayer HealthCare Pharmaceuticals | Stivarga | $61 | 3 payments
|
| Genzyme | Sarclisa | $56 | 3 payments
|
| Alexion Pharmaceuticals | Ultomiris | $53 | 2 payments
|
| Myovant Sciences | Orgovyx | $47 | 3 payments
|
| Janssen Biotech | Imbruvica | $46 | 3 payments
|
| Pharmacyclics LLC An AbbVie | Imbruvica | $42 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Opdivo | $40 | 2 payments
|
| Puma Biotechnology | Nerlynx | $34 | 2 payments
|
| Kite Pharma | Yescarta | $18 | 1 payment
|
| Celgene | Onureg | $17 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $17 | 1 payment
|
| EMD Serono | None | $15 | 1 payment
|
2020: $4,205
| Novartis Pharmaceuticals | Abl002 | $3,339 | 18 payments
|
| Amgen | Xgeva | $284 | 8 payments
|
| Puma Biotechnology | Nerlynx | $124 | 5 payments
|
| Merck Sharp & Dohme | Keytruda | $65 | 3 payments
|
| Dova Pharmaceuticals | Doptelet | $62 | 2 payments
|
| Genzyme | Jevtana | $52 | 3 payments
|
| Pfizer | Bosulif | $50 | 3 payments
|
| E.R. Squibb & Sons L.L.C. | Opdivo | $44 | 3 payments
|
| GlaxoSmithKline | Blenrep | $29 | 1 payment
|
| Janssen Biotech | Erleada | $25 | 1 payment
|
| Alexion Pharmaceuticals | Ultomiris | $22 | 1 payment
|
| Abbott Laboratories | Freestyle Libre | $22 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Stivarga | $20 | 1 payment
|
| Alnylam Pharmaceuticals | Givlaari | $18 | 1 payment
|
| EMD Serono | Bavencio | $18 | 1 payment
|
| BeiGene USA | Brukinsa | $17 | 1 payment
|
| Karyopharm Therapeutics | Xpovio | $12 | 1 payment
|
2019: $14,689
| Novartis Pharmaceuticals | Tasigna | $14,333 | 21 payments
|
| Janssen Biotech | Erleada | $148 | 4 payments
|
| Asd Specialty Healthcare | None | $67 | 1 payment
|
| Genentech USA | Perjeta | $65 | 3 payments
|
| Alexion Pharmaceuticals | Ultomiris | $32 | 1 payment
|
| Amgen | Evenity | $26 | 1 payment
|
| Verastem | Copiktra | $18 | 1 payment
|
Checkups this office reported
10 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 100.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Advance care plan on fileOlder patients with an advance care plan or a documented conversation about one | 100%That's most of the people this applied to. | 261 |
| Asked about alcoholPatients screened for unhealthy alcohol use, with counseling if needed | 100%That's most of the people this applied to. | 898 |
| Asked about smokingPatients asked about tobacco, with help to quit if they smoke | 100%That's most of the people this applied to. | 119 |
| Blood pressure under controlPeople with high blood pressure whose reading was in a healthy range | 76%That's most of the people this applied to. | 261 |
| Depression screeningPatients screened for depression, with a follow-up plan if needed | 83%That's most of the people this applied to. | 954 |
| Diabetes Mellitus: Diabetic Foot and Ankle Care, Peripheral Neuropathy - Neurological EvaluationAs Medicare defines this measure | 14% | 197 |
| Medications listed in the chartVisits where the current medication list was documented | 100%That's most of the people this applied to. | 3,966 |
| Screening for Osteoporosis for Women Aged 65-85 Years of AgeAs Medicare defines this measure | 53% | 127 |
See the other 2 measures
| Urinary Incontinence: Assessment of Presence or Absence of Urinary Incontinence in Women Aged 65 Years and OlderAs Medicare defines this measure | 100% | 158 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 100%That's most of the people this applied to. | 1,009 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Depression screening
- Diabetes screening
- Implementation of fall screening and assessment programs
- Tobacco use
Professional record
- NPI
- 1134124548
- Licence
- CA A41760California A41760: Current · expires 2028-07-31
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RH0003X (207RH0003X)
- Mailing address
- 350 Vinton Ave, Ste 101, Pomona, CA, 91767
- NPI first listed
- 2005-06-14
- NPI last updated
- 2025-05-21
- NPI record certified
- 2025-05-21
This is when the NPI record was last certified, not a medical board exam.